Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt

Journal of Viral Hepatitis

Volumn 18, Issue 7, 2011, Pages

  Vignier, N ^a   Esmat, G ^b,c   Elsharkawy, Aisha ^c   Hassany, M ^b   Bonnard, P ^d   Delarocque Astagneau, E ^a   Said, M ^e   Raafat, R ^f   El Hoseiny, M ^f   Fontanet, A ^a   Mohamed, M K ^b,f   Vray, M ^a,g  

^a INSTITUT PASTEUR   (France)

^b NATIONAL HEPATOLOGY AND TROPICAL MEDICINE RESEARCH INSTITUTE   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d HÔPITAL TENON   (France)

^e Cairo University   (Egypt)

^f AIN SHAMS UNIVERSITY   (Egypt)

^g INSERM   (France)

Author keywords

agreement; elastometry; reliability; repeatability; reproducibility; transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE;

ABDOMINAL WALL; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; DISEASE CLASSIFICATION; EGYPT; ELASTOGRAPHY; FEMALE; HEPATITIS C VIRUS; HEPATOBILIARY PARAMETERS; HUMAN; LIVER BIOPSY; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER SIZE; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTHROMBIN TIME; SCHISTOSOMA; STEATOSIS; VIRUS HEPATITIS; VIRUS INFECTION;

EID: 79959577270     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01433.x     Document Type: Article

References (35)

1. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-891. (Pubitemid 30137669)
2. Bedossa P, Dargere D, Paradis V,. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457. (Pubitemid 37466971)
3. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T,. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075. (Pubitemid 32322537)
4. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526. (Pubitemid 36919874)
5. Cales P, Oberti F, Michalak S, et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005; 42: 1373-1381. (Pubitemid 43260040)
6. Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007; 46: 32-36. (Pubitemid 47171918)
7. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350. (Pubitemid 40439195)
8. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54. (Pubitemid 40066382)
9. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-1713. (Pubitemid 38091720)
10. Foucher J, Castera L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006; 18: 411-412.
11. Sagir A, Erhardt A, Schmitt M, Haussinger D,. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47: 592-595. (Pubitemid 351280727)
12. Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47: 380-384. (Pubitemid 351280705)
13. Fraquelli M, Rigamonti C, Casazza G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-973. (Pubitemid 46999083)
14. Boursier J, Konate A, Guilluy M, et al. Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography. Eur J Gastroenterol Hepatol 2008; 20: 693-701.
15. Konate A, Reaud S, Quemener E, Fouchard-Hubert I, Oberti F, CalÃs P,. Liver stiffness measurement by transient elastography: predictive factors of accuracy, success and reproducibility. J Hepatol 2006; 44: S195.
16. Munteanu M, Ngo Y, De Torres M, et al. Three-dimensional and metabolic variability of Fibroscan (transient elastography) measures in healthy volunteers. Gastroenterology 2006; 130: A768.
17. Kim SU, Kim JK, Park JY, et al. Variability in liver stiffness values from different intercostal spaces. Liver Int 2009; 29: 760-766.
18. Boursier J, Konate A, Gorea G, et al. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol 2008; 6: 1263-1269.
19. Lucidarme D, Foucher J, Le Bail B, Castera L, Villars S, Forzy G,. The ratio interquartile range/median value of liver stiffness measurements is a key factor of accuracy of transient elastography (FibroScan) for the diagnosis of liver fibrosis. Hepatology 2007; 46: 318A.
20. Lucidarme D, Foucher J, Le Bail B, et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49: 1083-1089.
21. Ghany MG, Strader DB, Thomas DL, Seeff LB,. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374.
22. Bedossa P, Poynard T,. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293. (Pubitemid 26260021)
23. Bland J, Altman D,. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-310. (Pubitemid 16134762)
24. Euser AM, Dekker FW, le Cessie S,. A practical approach to Bland-Altman plots and variation coefficients for log transformed variables. J Clin Epidemiol 2008; 61: 978-982.
25. Shrout PE, Fleiss JL,. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 420-428.
26. Muller R, Buttner P,. A critical discussion of intraclass correlation coefficients. Stat Med 1994; 13: 2465-2476.
27. Rousselet MC, Michalak S, Dupre F, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41: 257-264. (Pubitemid 40165369)
28. Landis JR, Koch GG,. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174. (Pubitemid 8054849)
29. Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007; 14: 360-369. (Pubitemid 46587854)
30. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003; 49: 1-6. (Pubitemid 36078546)
31. Shaheen AA, Wan AF, Myers RP,. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol 2007; 102: 2589-2600. (Pubitemid 47631778)
32. Castera L, Forns X, Alberti A,. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-847.
33. Sebastiani G, Vario A, Guido M, et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006; 44: 686-693.
34. Castera L, Foucher J, Bertet J, Couzigou P, de Ledinghen V,. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology 2006; 43: 373-374. author reply 375-6.
35. Colletta C, Smirne C, Fabris C, et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005; 42: 838-845. (Pubitemid 41401121)